| Patents for C07D 401 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom (107,979) |
|---|
| 02/20/2008 | EP1888530A2 Quinoline derivatives as neurokinin receptor antagonists |
| 02/20/2008 | EP1888528A2 Phosphodiesterase 4 inhibitors |
| 02/20/2008 | EP1888517A1 Novel 8-sulfonylamino-3 aminosubstituted chroman or tetrahydronaphtalene derivatives modulating the 5ht6 receptor |
| 02/20/2008 | EP1740569B1 Imidazole derivatives used as tafia inhibitors |
| 02/20/2008 | EP1675832B1 Heterocyclyl compounds |
| 02/20/2008 | EP1613312B1 Benzimidazole derivatives and their use for modulating the gaba a receptor complex |
| 02/20/2008 | EP1603895B1 Substituted benzoylureidopyridyl-piperidine and -pyrrolidine carboxylic acid derivatives, method for the production thereof and the use thereof |
| 02/20/2008 | EP1556381B1 Pyrazole amides for treating hiv infections |
| 02/20/2008 | EP1432417B1 Substituted benzimidazole compounds and their use for the treatment of cancer |
| 02/20/2008 | CN101128456A Quinazoline derivatives as tyrosine kinase inhibitors |
| 02/20/2008 | CN101128455A Heterocyclylamide-substituted imidazoles |
| 02/20/2008 | CN101128454A Pyridine carboxamide derivatives for use as anticancer agents |
| 02/20/2008 | CN101128453A 2-sulfinyl- and 2-sulfonyl-substituted imidazole derivatives and their use as cytokine inhibitors |
| 02/20/2008 | CN101128452A Novel benzoimidazole derivatives and a pharmaceutical composition comprising the same |
| 02/20/2008 | CN101128439A 1,6 - substituted (3r,6r) -3- (2,3-dihydro-1h-inden-2-yl)-2,5-piperazinedione derivatives as oxytocin receptor antagonists for the treatment of pre-term labour, dysmenorrhea and endometriosis |
| 02/20/2008 | CN101128436A 甘氨酸衍生物及其用途 Glycine derivatives and their use |
| 02/20/2008 | CN101128434A Amide derivatives |
| 02/20/2008 | CN101128432A Tetrahydroisoquinoline compounds for treatment of cns disorders |
| 02/20/2008 | CN101128430A Pyridine compounds for the treatment of prostaglandin mediated diseases |
| 02/20/2008 | CN101128427A Heterocyclic compounds as ccr2b antagonists |
| 02/20/2008 | CN101128202A Farnesyl protein transferase inhibitors and methods for treating proliferative diseases |
| 02/20/2008 | CN101128199A Monocyclic heterocycles as kinase inhibitors |
| 02/20/2008 | CN100369904C 2-(replace- amino)-NOBS HIV prolease inhibitor |
| 02/20/2008 | CN100369899C Substituted indazoles with anti-cancer activity |
| 02/20/2008 | CN100369898C Nicotinamide derivates useful as p38 inhibitors |
| 02/20/2008 | CN100369888C N-alkanoylphenylalanine derivatives |
| 02/19/2008 | US7332605 reacting substituted 5,6,7,8-tetrahydroquinolinylamine bearing a phthalimide protecting group or a di-tert-butoxycarbonyl protecting group with an alkyl aldehyde to produce an imine; reduction with metal hydride; reacting the secondary amine with a 2-halomethylbenzimidazole; hydrolysis deprotecting |
| 02/19/2008 | US7332602 Pyridyl substituted heterocycles useful for treating or preventing HCV infection |
| 02/19/2008 | US7332512 Halogenated nitrobutadienes for controlling animal pests |
| 02/19/2008 | US7332511 Vanilloid receptor ligands and their use in treatments |
| 02/19/2008 | US7332510 Metabotropic glutamate (mGluR5) receptor mediated disorders; psychosis, epilepsy, schizophrenia, Alzheimer' disease, cognititve disorders, memory deficits, chronic and acute pain; containing pyridin-4-ylethynyl functionality |
| 02/19/2008 | US7332509 Used for controlling animal pests, in particular arthropods, such as insects and acarids, and helminths |
| 02/19/2008 | US7332506 Substituted-3-indolyl-4-piperidino-alkyl heterocycles for the treatment of depression |
| 02/19/2008 | US7332505 Gastrointestinal disorders; facilitating healing and decreasing recurrence of ulcers; low dosage, reduced side effects |
| 02/19/2008 | US7332504 Heterocyclic substituted aminoazacycles useful as central nervous system agents |
| 02/19/2008 | US7332501 Indol-3-yl-carbonyl-spiro-piperidine derivatives as V1a receptor antagonists |
| 02/19/2008 | US7332495 Aralkyl-ketone piperazine derivatives and their uses as new antalgic or ataractic agent |
| 02/19/2008 | US7332493 [3-Methyl-4-(pyridin-3-yloxy)-phenyl]-(6-piperidin-3-ylethynyl-quinazolin-4-yl)-amine; selective inhibitors of receptor tyrosine kinases and non-receptor tyrosine kinases (eg: Ick, src, abl) or serine/threonine kinases (e.g.: cyclin dependent kinases); carcinoma |
| 02/19/2008 | US7332492 Amino substituted dibenzothiophene derivatives for the treatment of disorders mediated by NP Y5 receptor |
| 02/19/2008 | US7332490 inhibit smooth muscle cell proliferation by modulating Heparan Sulfate Proteoglycans (HSPGs); inhibit or block glycated protein and Advanced Glycation Endproducts (AGE) produced induction of the signaling-associated inflammatory response in endothelial cells; antiproliferative and antiinflammatory agent |
| 02/19/2008 | US7332489 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332488 Methods and compositions of novel triazine compounds |
| 02/19/2008 | US7332487 Nitrogen-containing 5-membered ring compound |
| 02/19/2008 | US7332484 2,4-pyrimidinediamine compounds and their uses |
| 02/19/2008 | US7332483 3-(5-benzamido-2-chlorophenyl)-7-methoxy-3,4-dihydroquinazolin-4-one;cytokines (tumor necrosis factor and interleukins) inhibitor; antiinflammatory agent, rheumatoid arthritis, osteoarthritis, psoriasis, chronic obstructive pulmonary disease |
| 02/19/2008 | US7332481 Thrombopoietin mimetics |
| 02/19/2008 | US7332354 bioconjugation; luciferins; biopolymer labels |
| 02/19/2008 | US7332149 Diagnosis, therapy of cancer, rheumatoid arthritis, for monitoring therapeutic angiogenesis treatment and destruction of new angiogenic vasculature, imaging tumors, atherosclerosis, restenosis, cardiac ischemia, and myocardial reperfusion injury |
| 02/19/2008 | CA2307824C Processes for producing 7-isoindolinequinolonecarboxylic acid derivatives and intermediates therefor,salts of 7-isoindolinequinolonecarboxylic acids, hydrates thereof, and compositions containing the same as active ingredient. |
| 02/19/2008 | CA2287557C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 02/19/2008 | CA2287556C Block oligomers containing 1-hydrocarbyloxy-2,2,6,6-tetramethyl-4-piperidyl groups as stabilizers for organic materials |
| 02/19/2008 | CA2207100C Pyrimidine derivatives |
| 02/19/2008 | CA2113726C Use of tetrahydrocarbazone derivatives as 5ht1 receptor agonists |
| 02/14/2008 | WO2008019356A2 Process for the preparation of substituted-1,2,3,4-tetrahydroisoquinoline derivates |
| 02/14/2008 | WO2008019279A2 Synthesis of piperazines, piperidines and related compounds |
| 02/14/2008 | WO2008018639A2 Glycine transporter inhibitor |
| 02/14/2008 | WO2008018529A1 Novel pyrimidine compound having benzyl(pyridylmethyl)amine structure and pharmaceutical comprising the compound |
| 02/14/2008 | WO2008018306A1 Quinazoline derivative |
| 02/14/2008 | WO2008018091A1 Process for producing sulphoxide compounds |
| 02/14/2008 | WO2008017710A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | WO2008017685A1 Nitrate esters of piperidines |
| 02/14/2008 | WO2008017650A1 An aminoisoquinoline thrombin inhibitor with improved bioavailability |
| 02/14/2008 | WO2008017466A1 Pharmaceutically active tetrahydroisoquinoline-substituted benzimidazole derivatives |
| 02/14/2008 | WO2008008493A3 Alkyne-substituted pyridone compounds and methods of use |
| 02/14/2008 | WO2008002244A3 Imidazol-pyrimidine derivatives for treatment of diseases related to glycogen synthase kinase (gsk3) |
| 02/14/2008 | WO2008000950A3 Derivatives of ureas of piperidine or pyrrolidine, their preparation and their therapeutical use |
| 02/14/2008 | WO2007146066A3 Novel piperazines, pharmaceutical compositions and methods of use thereof |
| 02/14/2008 | WO2007139955A8 Triazole compounds that modulate hsp90 activity |
| 02/14/2008 | WO2007136302A3 Active substances, pharmaceutical composition and a method for the production and use thereof |
| 02/14/2008 | WO2007130780A3 Benzimidazole modulators of vr1 |
| 02/14/2008 | WO2007127262A3 Enantiomers of 2'-fluoralkyl-6-nitroquipazine as serotonin transporter positron emission tomography imaging agents and antidepressant therapeutics |
| 02/14/2008 | WO2007083017A3 Novel cyclic urea derivatives, preparation thereof and pharmaceutical use thereof as kinase inhibitors |
| 02/14/2008 | WO2007018248A9 Pyridone compound |
| 02/14/2008 | US20080039662 Isomerizing an alkyl cis-4-(alkylsulfonylamino)cyclohexanecarboxylate to form the trans isomer with a base (alkali metal lower alkoxide, hydride or amide) in an aprotic solvent (toluene); forming the free acid by hydrolysis; sulfonation of alkyl 4-aminocyclohexanecarboxylate with alkylsulfinyl chloride |
| 02/14/2008 | US20080039631 Process For Preparing N-(Substituted Arylmethyl) -4-Substituted-4-(Disubstituted Methyl) Piperidines And Intermediates |
| 02/14/2008 | US20080039630 Cyanine compounds and their application as quenching compounds |
| 02/14/2008 | US20080039625 Screening Methods |
| 02/14/2008 | US20080039622 2,4-pyrimidinediamine compounds and their uses |
| 02/14/2008 | US20080039504 ethyl 5-(5-chloro-3-(4-chloro-3-(trifluoromethyl) phenylsulfonamido)pyridin-2-yl)-4-(isoxazol-3-yl)-4H-1,2,4-triazole-3-carboxylate; inflammation; chemokine receptor (CCR 9 or 2) antagonists |
| 02/14/2008 | US20080039503 Process For The Preparation Of Crystalline Modifications For Use In The Preparation Of Esomeperazole Sodium Salt |
| 02/14/2008 | US20080039480 Quinazolinedione Derivatives as Parp Inhibitors |
| 02/14/2008 | US20080039479 Compounds and therapeutical use thereof |
| 02/14/2008 | US20080039474 Novel heterocyclic substituted pyridine compounds with cxcr3 antagonist activity |
| 02/14/2008 | US20080039472 Inhibitors of the Interaction Between Mdm2 and P53 |
| 02/14/2008 | US20080039468 Novel 3-Phenyltetrahydrocinnolin-5-Ol Derivative and Medicinal Use Thereof |
| 02/14/2008 | US20080039462 Compounds having 5-HT6 receptor affinity |
| 02/14/2008 | US20080039454 Urotensin II receptor antagonists |
| 02/14/2008 | US20080039450 Compounds |
| 02/14/2008 | US20080039449 [1,4]benzodiazepine derivatives, used for treating osteoarthritis, pancreatitis, glomerulonephritis, rheumatoid arthritis, inflammatory bowel disease, Crohn's disease, psoriasis, graft vs host disease, leukemia, septic shock, multiple sclerosis, and inflammatory bowel disease |
| 02/14/2008 | US20080039447 CDK-Inhibitory pyrimidines, their production and use as pharmaceutical agents |
| 02/14/2008 | US20080039446 Substituted isoindoles and their use |
| 02/14/2008 | US20080039440 such as 6-(6-Amino-pyrimidin-4-yloxy)-3,4-dihydro-2H-quinoline-1-carboxylic acid (3-trifluoromethyl-phenyl)-amide, used for the treatment of leukemia |
| 02/14/2008 | US20080038357 Inhalation Powder Containing the CGRP antagonist BIBN4096 and Process for the Preparation Thereof |
| 02/14/2008 | US20080038276 carbamimidoyl benzylamide derivatives; preventing and treating the formation of thrombin during or after a PK dependent disease or condition after fibrinolysis treatment |
| 02/14/2008 | US20080038225 Triazolyl acyclic hepatitis c serine protease inhibitors |
| 02/14/2008 | US20080036373 Platinum complex and light-emitting device |
| 02/14/2008 | CA2660704A1 Indole compounds |
| 02/14/2008 | CA2660538A1 Nitrate esters of piperidines |
| 02/14/2008 | CA2660421A1 1h-quinolin-4-one compounds, with affinity for the gaba receptor, processes, uses and compositions |
| 02/14/2008 | CA2660112A1 Process for producing sulphoxide compounds |